Updated 2026-09-08 · NCT07803809See eligibility →
Sponsor
Clinical trials sponsored by Shanghai Minwei Biotechnology Co., Ltd
Active studies whose public registry record names Shanghai Minwei Biotechnology Co., Ltd as lead sponsor.
8active studies
4recruiting now
2countries represented
2largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Updated 2026-09-03 · NCT07801820See eligibility →
Recruiting nowPhase 1
A Study to Evaluate MWN109 Tablets in Healthy Adult Participants
Updated 2025-11-20 · NCT06938269See eligibility →
Recruiting nowPhase 1
A Study to Evaluate MWN109 Injection in Healthy Subjects
Updated 2025-04-15 · NCT06859853See eligibility →
Updated 2026-08-24 · NCT07779980See eligibility →
Opening soonPhase 3
Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity
Updated 2026-08-21 · NCT07778693See eligibility →
Active, not recruitingPhase 2
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or Obesity
Updated 2026-09-04 · NCT07804797See eligibility →
Active, not recruitingPhase 2
Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight
Updated 2026-08-28 · NCT07791537See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.